Central Retinal Vein Occlusion

Retina: Fourth Edition

Volumn 2-3, Issue , 2005, Pages 1339-1348

  Mruthyunjaya, Prithvi ^a   Fekrat, Sharon ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955398836     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02598-0.50076-8     Document Type: Chapter

References (67)

1. Hayreh SS, Zimmerman MB, Podhajsky P Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994, 117:429-441.
2. Mitchell P, Smith W, Chang A Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996, 114:1243-1247.
3. Group TCVOS Baseline and early natural history report: the Central Vein Occlusion Study. Arch Ophthalmol 1993, 111:1087-1095.
4. Fekrat S, Finkelstein D Venous Occlusive Disease. Vitreoretinal disease: the essentials 1999, Thieme, New York. 1st edn. C.D. Regillo, G.C. Brown, H.W. Flynn (Eds.).
5. Gutman FA Evaluation of a patient with central retinal vein occlusion. Ophthalmology 1983, 90:481-483.
6. Fong AC, Schatz H Central retinal vein occlusion in young adults. Surv Ophthalmol 1993, 38:88.
7. Deramo VA, Cox TA, Syed AB, et al. Vision-related quality of life in people with central retinal vein occlusion using the 25-item National Eye Institute Visual Function Questionnaire. Archives of Ophthalmology 2003, 121:1297-1302.
8. Klein R, Klein BE, Moss SE, Meuer SM The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000, 98:133-141. discussion 41-43.
9. Group TCVOS Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997, 115:486-491.
10. Hayreh SS Central retinal vein occlusion. Ophthalmol Clin North Am 1998, 11:559-590.
11. Browning DJ Patchy ischemic retinal whitening in acute central retinal vein occlusion. Ophthalmology 2002, 109:2154-2159.
12. Brown GC, Duker JS, Lehman R, et al. Combined central retinal artery-central vein obstruction. Int Ophthalmol 1993, 17:9-17.
13. Ciardella AP, Clarkson JG, Guyer DR, et al. Central retinal vein occlusion: a primer and review. Retina-Vitreous-Macular 1999, W.B. Saunders, New York. L.A. Yannuzzi (Ed.).
14. Browning DJ, Scott AQ, Peterson CB, et al. The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology 1998, 105:776-784.
15. Clarkson JG Central Vein Occlusion Study: photographic protocol and early natural history. Trans Am Ophthalmol Soc 1994, 92:203-213. discussion 13-15.
16. Hayreh SS, Klugman MR, Beri M, et al. Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. Graefes Arch Clin Exp Ophthalmol 1990, 228:201-217.
17. Green W, Chan C, Hutchins G, et al. Central retinal vein occlusions: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1981, 1:27-55.
18. Pe'er J, Folberg R, Itin A, et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 1998, 105:412-416.
19. Boyd SR, Zachary I, Chakravarthy U, et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol 2002, 120:1644-1650.
20. The Eye Disease Case-Control Study Group Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996, 114:545-554.
21. Elman MJ, Bhatt AK, Quinlan PM, et al. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology 1990, 97:1543-1548.
22. Hayreh SS, Zimmerman B, McCarthy MJ, et al. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001, 131:61-77.
23. Martin SC, Butcher A, Martin N, et al. Cardiovascular risk assessment in patients with retinal vein occlusion [comment]. Br J Ophthalmol 2002, 86:774-776.
24. Lahey JM, Tunc M, Kearney J, et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 2002, 109:126-131.
25. Williamson TH, Rumley A, Lowe GD Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 1996, 80:203-208.
26. Abu El-Asrar AM, Abdel Gader AG, Al-Amro S, et al. Hypercoagulable states in patients with retinal venous occlusion. Doc Ophthalmol 1998, 95:133-143.
27. Hayreh SS, Zimmerman MB, Podhajsky P Hematologic abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002, 240:180-196.
28. Gottlieb JL, Blice JP, Mestichelli B, et al. Activated protein C resistance, factor V Leiden, and central retinal vein occlusion in young adults. Arch Ophthalmol 1998, 116:577-579.
29. Hvarfner C, Hillarp A, Larsson J Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion. Br J Ophthalmol 2003, 87:305-306.
30. Cahill MT, Stinnett SS, Fekrat S Meta-analysis of plasma homocysteine, serum folate, serum vitamin B, and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003, 136:1136-1150.
31. Francis PJ, Stanford MR, Graham EM Dehydration is a risk factor for central retinal vein occlusion in young patients. Acta Ophthalmol Scand 2003, 81:415-416.
32. Rumelt S, Karatas M, Pikkel J, et al. Optic disc traction syndrome asso-ciated with central retinal vein occlusion. Arch Ophthalmol 2003, 121:1093-1097.
33. Kearnes TP Differential diagnosis of central retinal vein obstruction. Ophthalmology 1983, 90:475-480.
34. Lai JC, Mruthyunjaya P, Fekrat S Central retinal vein occlusion in patients on chronic Coumadin® anticoagulation. Invest Ophthalmol Vis Sci 2002, 42. ARVO E-Abstract 519.
35. Browning DJ, Fraser CM Retinal vein occlusions in patients taking warfarin. Ophthalmology 2004, 111:1196-1200.
36. De Sanctis MT, Cesarone MR, Belcaro G, et al. Treatment of retinal vein thrombosis with pentoxifylline: a controlled, randomized trial. Angiology 2002, 53(Suppl 1):S35-S38.
37. Wolf S, Arend O, Bertram B, et al. Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 1994, 232:33-39.
38. Shaikh S, Blumenkranz MS Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and anti-inflammatory therapy. Retina 2001, 21:176-178.
39. Fekrat S, de Juan E Chorioretinal venous anastomosis for central retinal vein occlusion: transvitreal venipuncture. Ophthal Surg Lasers 1999, 30:52-55.
40. Fekrat S, Goldberg MF, Finkelstein D Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion [comment]. Arch Ophthalmol 1998, 116:43-52.
41. Browning DJ, Antoszyk AN Laser chorioretinal venous anastomosis for nonischemic central retinal vein occlusion. Ophthalmology 1998, 105:670-677. discussion 7-9.
42. McAllister IL, Constable IJ Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion [comment]. Arch Ophthalmol 1995, 113:456-462.
43. McAllister IL, Douglas JP, Constable IJ, et al. Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 1998, 126:219-229.
44. Browning D, Rotberg M Vitreous hemorrhage complicating laser-induced chorioretinal anastomosis for central retinal vein occlusion. Am J Ophthalmol 1996, 122:588-589.
45. Kwok AK, Lee VY, Lai TY, et al. Laser induced chorioretinal venous anastomosis in ischaemic central retinal vein occlusion. Br J Ophthalmol 2003, 87:1043-1044.
46. Lam HD, Blumenkranz MS Treatment of central retinal vein occlusion by vitrectomy with lysis of vitreopapillary and epipapillary adhesions, subretinal peripapillary tissue plasminogen activator injection, and photocoagulation. Am J Ophthalmol 2002, 134:609-611.
47. Yeshaya A, Treister G Pars plana vitrectomy for vitreous hemorrhage and retinal vein occlusion. Ann Ophthalmol 1983, 15:615-617.
48. Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: A retrospective pilot study of 11 consecutive cases. Retina 2001, 21:408-415.
49. Dev S, Buckley EG Optic nerve sheath decompression for progressive central retinal vein occlusion. Ophthal Surg Lasers 1999, 30:181-184.
50. Vasco-Posada J Modification of the circulation in the posterior pole of the eye. Ann Ophthalmol 1972, 4:48-59.
51. Weizer JS, Stinnett SS, Fekrat S Radial optic neurotomy as treatment for central retinal vein occlusion. Am J Ophthalmol 2003, 136:814-819.
52. Garcia-Arumi J, Boixadera A, Martinez-Castillo V, et al. Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. Arch Ophthalmol 2003, 121:1385-1391.
53. Williamson TH, Poon W, Whitefield L, et al. A pilot study of pars plana vitrectomy, intraocular gas, and radial neurotomy in ischaemic central retinal vein occlusion. Br J Ophthalmol 2003, 87:1126-1129.
54. Hattenbach LO, Steinkamp G, Scharrer I, et al. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. Ophthalmologica 1998, 212:394-398.
55. Hattenbach LO, Wellermann G, Steinkamp GW, et al. Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion. Ophthalmologica 1999, 213:360-366.
56. Lahey JM, Fong DS, Kearney J Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthal Surg Lasers 1999, 30:427-434.
57. Glacet-Bernard A, Kuhn D, Vine AK, et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000, 84:609-613.
58. Elman MJ, Raden RZ, Carrigan A Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001, 99:219-221. discussion 22-23.
59. Ghazi NG, Noureddine BN, Haddad RS, et al. Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina 2003, 23:780-784.
60. Weiss JN Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 1998, 126:142-144.
61. Paques M, Vallee JN, Herbreteau D, et al. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol 2000, 84:1387-1391.
62. Weiss JN, Bynoe LA Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001, 108:2249-2257.
63. Bynoe LA, Weiss JN Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol 2003, 135:382-384.
64. Jonas JB, Kreissig I, Degenring RF Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graef Arch Clin Exp Ophthalmol 2002, 240:782-783.
65. Ip MS, Kumar KS Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002, 120:1217-1219.
66. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002, 86:247-248.
67. Park CH, Jaffe GJ, Fekrat S Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003, 136:419-425.